Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Ferrant

Showing results (21-30 of 234) with videos related to

Pageof 24
Sort By:
The American Journal of Medicine|January 1, 1989
Sweet's syndrome and myelodysplastic syndrome in a patient with metastatic breast carcinomaQ Meulders, A Allal, S Eggers, et al.
Annals of Hematology|March 22, 2002
Hodgkin's disease and hypothermia: case report and review of the literatureV Robin, J Lebacq, L Michaux, et al.
Annals of Hematology|July 1, 1997
Pericarditis induced by high-dose cytosine arabinoside chemotherapyC Hermans, N Straetmans, J L Michaux, et al.
Leukemia|May 21, 1998
Stromal factors support the expansion of the whole hemopoietic spectrum from bone marrow CD34+DR- cells and of some hemopoietic subsets from CD34+ and CD34+DR+ cellsP Herman, A Ferrant, M De Bruyère, et al.
Acta Clinica Belgica|January 1, 1989
Low-dose cytosine arabinoside in myelodysplastic syndromesP Mineur, P Martiat, A Ferrant, et al.
Acta Clinica Belgica|June 26, 2008
Clinical implications of JAK2 mutations in myeloproliferative disordersL Knoops, C Hermans, A Ferrant, et al.
Acta Clinica Belgica|January 1, 1986
Low-dose cytosine arabinoside in myelodysplastic syndromesP Martiat, P Mineur, A Ferrant, et al.
Clinical Nephrology|January 7, 1999
Splenic lymphoma presenting as necrotizing glomerulonephritisT Messiaen, J P Cosyns, A Ferrant, et al.
Hematological Oncology|October 1, 1988
Intensive chemotherapy for acute non-lymphoblastic leukemia after primary myelodysplastic syndromeP Martiat, A Ferrant, J L Michaux, et al.
Nouvelle Revue Francaise D'Hematologie; Blood Cells|May 1, 1977
[Skeletal and medullary involvement in Hodgkin's disease]A Ferrant, J Rodhain, J L Michaux, et al.
Pageof 24

Showing results (21-30 of 234) with videos related to

Sort By:
Pageof 24
The American Journal of Medicine|January 1, 1989
Sweet's syndrome and myelodysplastic syndrome in a patient with metastatic breast carcinomaQ Meulders, A Allal, S Eggers, et al.
Annals of Hematology|March 22, 2002
Hodgkin's disease and hypothermia: case report and review of the literatureV Robin, J Lebacq, L Michaux, et al.
Annals of Hematology|July 1, 1997
Pericarditis induced by high-dose cytosine arabinoside chemotherapyC Hermans, N Straetmans, J L Michaux, et al.
Leukemia|May 21, 1998
Stromal factors support the expansion of the whole hemopoietic spectrum from bone marrow CD34+DR- cells and of some hemopoietic subsets from CD34+ and CD34+DR+ cellsP Herman, A Ferrant, M De Bruyère, et al.
Acta Clinica Belgica|January 1, 1989
Low-dose cytosine arabinoside in myelodysplastic syndromesP Mineur, P Martiat, A Ferrant, et al.
Acta Clinica Belgica|June 26, 2008
Clinical implications of JAK2 mutations in myeloproliferative disordersL Knoops, C Hermans, A Ferrant, et al.
Acta Clinica Belgica|January 1, 1986
Low-dose cytosine arabinoside in myelodysplastic syndromesP Martiat, P Mineur, A Ferrant, et al.
Clinical Nephrology|January 7, 1999
Splenic lymphoma presenting as necrotizing glomerulonephritisT Messiaen, J P Cosyns, A Ferrant, et al.
Hematological Oncology|October 1, 1988
Intensive chemotherapy for acute non-lymphoblastic leukemia after primary myelodysplastic syndromeP Martiat, A Ferrant, J L Michaux, et al.
Nouvelle Revue Francaise D'Hematologie; Blood Cells|May 1, 1977
[Skeletal and medullary involvement in Hodgkin's disease]A Ferrant, J Rodhain, J L Michaux, et al.
Pageof 24